Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nair Radhakrishnan

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|December 3, 2019
Author's RebuttalNair Radhakrishnan, Deepu George, Radhakrishnan Jayakrishnan, et al.
Cell Death & Disease|November 4, 2025
A novel strategy to target metabolic dependencies in acute myeloid leukemiaNithya Balasundaram, Hamenth Kumar Palani, Arvind Venkatraman, et al.
Molecular Therapy. Oncology|April 18, 2025
Safety, efficacy and total cost of point-of-care manufactured anti-CD19 CAR-T cell therapy in India: VELCART trialHamenth Kumar Palani, Arun Kumar Arunachalam, Uday Kulkarni, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|December 3, 2019
Author's RebuttalNair Radhakrishnan, Deepu George, Radhakrishnan Jayakrishnan, et al.
Cell Death & Disease|November 4, 2025
A novel strategy to target metabolic dependencies in acute myeloid leukemiaNithya Balasundaram, Hamenth Kumar Palani, Arvind Venkatraman, et al.
Molecular Therapy. Oncology|April 18, 2025
Safety, efficacy and total cost of point-of-care manufactured anti-CD19 CAR-T cell therapy in India: VELCART trialHamenth Kumar Palani, Arun Kumar Arunachalam, Uday Kulkarni, et al.
Pageof 1